Latest News
-
Mayo Clinic develops breakthrough tool to predict Alzheimer’s risk years before symptoms appear
The study revealed that women face a higher lifetime risk than men of developing dementia and mild cognitive impairment (MCI), a transitional stage between healthy aging and dementia.
-
Trust Fertility Clinic celebrates milestone first year with 2,000+ successful IVF cycles
Since opening its doors in October 2024, Trust Fertility Clinic has established itself as a pioneer in science-led and innovation-driven fertility care.
-
Moscow scientists present 14 realistic anatomical phantoms for medical training
Doctors now use these highly realistic training tools to master complex surgical procedures, refine ultrasound diagnostic techniques, and verify the accuracy of CT and MRI imaging equipment.
-
Variant Bio names Dr. Craig Basson as Chief Medical Officer to oversee clinical development strategy
Dr. Basson joins Variant Bio with more than 25 years of leadership experience spanning academic medicine, global pharmaceutical development, and biotechnology sectors.
-
US officially exits WHO after year-long withdrawal process
President Donald Trump initiated this process exactly one year ago when he signed an executive order on his first day in office in 2025, pointing to what he described as the organization’s “mishandling of the COVID-19 pandemic” and its response to “other global health crises.”
-
CS Duale commissions advanced catheterization lab at AGC Tenwek in Bomet
AGC Tenwek Hospital operates 17 operating theatres alongside 44 ICU and HDU beds, providing critical care capacity that few facilities in the region can match.
-
Egypt advances local production of critical childhood vaccines through international partnership
The partnership specifically targets the domestic manufacture of PCV13 using VACSERA’s established production facilities and infrastructure within Egypt.
-
Exciva secures USD59M in Series B funding to advance Alzheimer’s agitation treatment
The company plans to use the funding primarily to support a phase 2 clinical study evaluating Deraphan, its experimental treatment for agitation in patients with Alzheimer’s disease.
-
Roche triples investment in North Carolina manufacturing plant to USD2B for obesity drug production
The plant is scheduled to begin operations by 2029 and will focus on producing cutting-edge treatments for metabolic conditions, particularly obesity medications.
-
JOOTRH launches advanced maternal health study to reduce delivery complications in Kenya
The initiative represents a collaborative effort between JOOTRH, the Kenya Medical Research Institute (KEMRI), and the Liverpool School of Tropical Medicine.